|
|
|
Insider
Information: |
Gershkowitz Jayne |
Relationship: |
SVP, Chief Patient Adv... |
City: |
Cranbury |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
5,693 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$60,403 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
5,693 |
|
|
Total
Value |
$60,403 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amicus Therapeutics Inc |
FOLD |
SVP, Chief Patient Adv... |
2015-07-01 |
5,693 |
2014-04-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FOLD |
Amicus Therapeutics Inc |
VP, Patient Advocacy |
|
2014-08-25 |
4 |
AB |
$6.00 |
$30,000 |
D/D |
5,000 |
55,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
VP, Patient Advocacy |
|
2014-08-25 |
4 |
AS |
$6.00 |
$30,000 |
D/D |
(5,000) |
50,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
VP, Patient Advocacy |
|
2014-08-27 |
4 |
AB |
$7.00 |
$35,000 |
D/D |
5,000 |
55,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
VP, Patient Advocacy |
|
2014-08-27 |
4 |
AS |
$7.00 |
$35,000 |
D/D |
(5,000) |
50,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
VP, Patient Advocacy |
|
2014-08-20 |
4 |
AB |
$5.40 |
$32,832 |
D/D |
6,080 |
56,080 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
VP, Patient Advocacy |
|
2014-08-20 |
4 |
AS |
$5.40 |
$32,832 |
D/D |
(6,080) |
50,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
SVP, Chief Patient Advocate |
|
2015-05-08 |
4 |
D |
$10.80 |
$100,516 |
D/D |
(9,307) |
15,693 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
SVP, Chief Patient Advocate |
|
2015-05-11 |
4 |
AS |
$10.84 |
$108,389 |
D/D |
(10,000) |
5,693 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
VP, Patient Advocacy |
|
2015-03-20 |
4 |
AS |
$11.51 |
$122,568 |
D/D |
(10,648) |
50,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
VP, Patient Advocacy |
|
2015-03-20 |
4 |
OE |
$11.51 |
$122,568 |
D/D |
10,648 |
60,648 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
SVP, Chief Patient Advocate |
|
2015-07-01 |
4 |
OE |
$13.97 |
$148,818 |
D/D |
10,649 |
16,342 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
SVP, Chief Patient Advocate |
|
2015-07-01 |
4 |
AS |
$13.97 |
$148,818 |
D/D |
(10,649) |
5,693 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
SVP, Chief Patient Advocate |
|
2015-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
VP, Patient Advocacy |
|
2014-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|